R
Rachel S Simpson
Researcher at Queen's University
Publications - 7
Citations - 115
Rachel S Simpson is an academic researcher from Queen's University. The author has contributed to research in topics: Dupilumab & Omalizumab. The author has an hindex of 3, co-authored 7 publications receiving 65 citations.
Papers
More filters
Journal ArticleDOI
Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria.
Jason K Lee,Rachel S Simpson +1 more
Journal ArticleDOI
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease.
TL;DR: It was postulated by the authors to investigate dupilumab as a novel steroid-sparing treatment for IgG4-RD.
Journal ArticleDOI
Omalizumab as single-dose therapy for vernal keratoconjunctivitis.
Rachel S Simpson,Jason K Lee +1 more
Journal ArticleDOI
Response to: ‘Dupilumab as a potential steroid-sparing treatment for IgG4-related disease’ by Della-Torre et al
Rachel S Simpson,Jason K Lee +1 more
TL;DR: It is proposed that dupilumab, a monoclonal anti-interleukin 4 (IL-4) and IL-13 antibody, would be able to treat the patient’s condition mechanistically through two pathways, and that IgG4-RD is an example of type 2 inflammation, similar to other conditions that have been misclassified as non-type 2 inflammation in the past.